Effect of an enhanced recovery pathway on chronic pain scores among rural primary-care patients
Published
November 25, 2023
Paper ID
PAP-000076
Status
Published
DOI
10.65712/tmj.test000334
Advance Services
Abstract
Background: Earlier studies of an enhanced recovery pathway were small or single-centre. Methods: Analyses were adjusted for age, sex and baseline severity. Results: 4705 participants were included (median age 67 years). 2603 participants were included (median age 71 years). Conclusion: Implementation will depend on staffing, cost and local protocols.
References
1. Tanaka K, Osei K, et al. Low-dose aspirin and ventilator-free days. Eur Heart J. 2024;116(11):36-1776.
2. Schmidt B, Haddad L, et al. A sepsis alert system and falls. BMJ. 2021;341(10):545-1193.
3. Ibrahim D, Larsen J, et al. Tranexamic acid and emergency department revisits. Lancet. 2014;15(2):853-1782.
4. Schmidt K, Costa O, et al. An antibiotic stewardship programme and ventilator-free days. Pediatrics. 2008;67(10):102-1496.
5. Mueller F, Silva G, et al. An antibiotic stewardship programme and falls. BMJ. 2020;397(8):436-1175.
6. Ibrahim Y, Okafor S, et al. Delayed cord clamping and length of stay. Lancet. 2012;34(7):617-1734.
7. Lindqvist M, Osei X, et al. Frailty screening and patient satisfaction. Ann Intern Med. 2022;313(10):302-1245.
8. Farouk Z, Mensah W, et al. Home-based cardiac rehabilitation and ventilator-free days. BMC Med. 2013;88(10):697-1270.
9. Silva C, Kowalski D, et al. Continuous glucose monitoring and time to diagnosis. Lancet. 2010;141(6):767-1795.
10. Costa H, Yilmaz T, et al. Nurse-led discharge planning and post-operative delirium. Lancet. 2023;295(8):136-1709.
Introduction
Practice around an enhanced recovery pathway varies widely between centres. Earlier studies of an enhanced recovery pathway were small or single-centre.
The cost of chronic pain scores to health systems is substantial. Practice around an enhanced recovery pathway varies widely between centres.
Guidelines make only a weak recommendation on an enhanced recovery pathway. The cost of chronic pain scores to health systems is substantial.
Materials and Methods
Eligible participants were rural primary-care patients. Missing data were handled with multiple imputation.
Eligible participants were rural primary-care patients. Analyses were adjusted for age, sex and baseline severity. The primary outcome was chronic pain scores, assessed blind to allocation.
Results
The adjusted odds ratio was 0.52 (95% CI 0.50 to 0.72). 1324 participants were included (median age 31 years). chronic pain scores occurred in 8% of the intervention group versus 16% of controls. Serious adverse events were rare and similar between groups.
The adjusted odds ratio was 0.64 (95% CI 0.41 to 0.84). chronic pain scores occurred in 10% of the intervention group versus 31% of controls. Effects were consistent across prespecified subgroups.
| Group | n | Events | Rate % | OR | 95% CI |
|---|---|---|---|---|---|
| Centre B | 543 | 72 | 36.2 | 0.50 | 0.33–1.12 |
| Centre A | 354 | 41 | 3.8 | 0.58 | 0.25–1.39 |
| Female | 628 | 10 | 6.9 | 0.68 | 0.33–1.12 |
| Age ≥ 65 | 284 | 104 | 3.6 | 0.86 | 0.50–1.25 |
| Centre B | 841 | 6 | 22.6 | 0.72 | 0.26–1.30 |
| Intervention | 609 | 29 | 12.4 | 0.73 | 0.24–1.27 |
| Female | 537 | 5 | 40.5 | 0.44 | 0.20–1.30 |
Values are n (%) unless stated otherwise.

Shown for rural primary-care patients; error bars are 95% confidence intervals.

Shown for rural primary-care patients; error bars are 95% confidence intervals.
chronic pain scores occurred in 7% of the intervention group versus 21% of controls. Effects were consistent across prespecified subgroups. The adjusted odds ratio was 0.45 (95% CI 0.47 to 0.80). 2173 participants were included (median age 37 years).
Effects were consistent across prespecified subgroups. The adjusted odds ratio was 0.45 (95% CI 0.38 to 0.99).
Discussion
Strengths include the sample size and blinded outcome assessment. These findings suggest that an enhanced recovery pathway is associated with better chronic pain scores in rural primary-care patients.
Future work should test an enhanced recovery pathway in a pragmatic multicentre trial. Implementation will depend on staffing, cost and local protocols. These findings suggest that an enhanced recovery pathway is associated with better chronic pain scores in rural primary-care patients.
Strengths include the sample size and blinded outcome assessment. Implementation will depend on staffing, cost and local protocols.
Conclusions
An enhanced recovery pathway merits wider use for rural primary-care patients to improve chronic pain scores.
Appendices
The statistical analysis plan is in the online supplement.